Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BiltRx vs Bioverse

By GLP-1 ScorecardUpdated

BiltRx
Site position #59

Higher grade

Bioverse
Site position #330

Lower grade

Score comparison

BiltRx has the higher recorded score — 75.3/100 to 61.4/100.

BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueBiltRx +23
91
68
Dose & formulationBiltRx +8
85
77
Clinical oversightBiltRx +19
74
55
Labs & monitoringBioverse +1
52
53
FulfillmentBiltRx +9
71
62
Contract termsBiltRx +22
55
33
BiltRx · top barBioverse · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBiltRxBioverse
WeighScore75.3/10061.4/100
GradeCC
Site position#59#330
Semaglutide$125/mo (all doses, compounded)$129/mo (starting dose, compounded)
Tirzepatide$129/mo (all doses, compounded)$399/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
BiltRx

Site position #59 · C

Strengths

  • Very low starting prices (semaglutide from 125 dollars, tirzepatide from 129 dollars)
  • LegitScript verified and HIPAA compliant
  • Names its 503A compounding pharmacies (Boothwyn and Southend)
  • Offers both compounded and brand-name GLP-1 options

What to consider

  • Covered states are behind a check-availability gate, not listed
  • Starting prices may rise depending on plan and dose
Bioverse

Site position #330 · C

FDAWarning letter issued to Bioverse, Inc. dba Bioverse in September 2025. See the FDA warning-letter database.

Strengths

  • Wide formulary — compounded and brand-name semaglutide + tirzepatide plus metformin
  • No membership, cancellation, doctor, or hidden fees
  • Uses US-licensed, FDA-regulated pharmacies

What to consider

  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed beyond 'a provider licensed in your state'
  • Broader longevity platform (NAD+, B12, glutathione, hair, skincare, heart health) rather than GLP-1 focused
  • FDA issued Bioverse, Inc. dba Bioverse a warning letter in September 2025; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard